- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mangalam Drugs and Organics Ltd (MADR)
Mangalam Drugs and Organics Ltd stock price live, this page displays NSE MADR stock exchange data. View the MADR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mangalam Drugs and Organics Ltd real time stock price chart below.
What Is the Mangalam Drugs and Organics Ltd Stock Price Today?
The Mangalam Drugs and Organics Ltd stock price today is 82.75.
What Is the Stock Symbol for Mangalam Drugs and Organics Ltd?
The stock symbol for Mangalam Drugs and Organics Ltd is ""MADR.""
What Stock Exchange Does Mangalam Drugs and Organics Ltd Trade On?
Mangalam Drugs and Organics Ltd is listed and trades on the NSE stock exchange.
Is Mangalam Drugs and Organics Ltd a Good Stock to Buy?
Determining whether Mangalam Drugs and Organics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MADR quote. (ISIN: INE584F01014)
What Is the Mangalam Drugs and Organics Ltd Stock Price Today?
The Mangalam Drugs and Organics Ltd stock price today is 82.75.
What Is the Stock Symbol for Mangalam Drugs and Organics Ltd?
The stock symbol for Mangalam Drugs and Organics Ltd is ""MADR.""
What Stock Exchange Does Mangalam Drugs and Organics Ltd Trade On?
Mangalam Drugs and Organics Ltd is listed and trades on the NSE stock exchange.
Is Mangalam Drugs and Organics Ltd a Good Stock to Buy?
Determining whether Mangalam Drugs and Organics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MADR quote. (ISIN: INE584F01014)
82.75
+8.39(+11.28%)
Closed·
Fair Value
An estimate of a Mangalam Drugs Organics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.50
86.90
52 wk Range
70.10
144.99
MADR Scorecard
Full Analysis
High shareholder yield
Unusual trading volume
1/2
Fair Value
An estimate of a Mangalam Drugs Organics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.5086.90
52 wk Range
70.10144.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MADR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Mangalam Drugs Organics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Mangalam Drugs and Organics Ltd Company Profile
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; and ortho phenoxy methane sulfonanilide, tenofovir alafenamide base, and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol; bictegravir Na, aripiprazole, risperidone, olanzapine, and etodolac; and develops tafenoquine succinate and pretomanid. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. The company was incorporated in 1972 and is based in Mumbai, India.
Compare MADR to Peers and Sector
Metrics to compare | MADR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMADRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.6x | 5.2x | −0.5x | |
PEG Ratio | 0.03 | 0.14 | 0.00 | |
Price/Book | 0.9x | 1.2x | 2.6x | |
Price / LTM Sales | 0.4x | 1.1x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 40.1% | |
Fair Value Upside | Unlock | 8.5% | 5.1% | Unlock |
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-8.72 / --
Revenue / Forecast
572.09M / --
People Also Watch
FAQ
What Stock Exchange Does Mangalam Drugs Organics Trade On?
Mangalam Drugs Organics is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Mangalam Drugs Organics?
The stock symbol for Mangalam Drugs Organics is "MADR."
What Is the Mangalam Drugs Organics Market Cap?
As of today, Mangalam Drugs Organics market cap is 1.32B.
What Is Mangalam Drugs Organics's Earnings Per Share (TTM)?
The Mangalam Drugs Organics EPS (TTM) is -6.17.
From a Technical Analysis Perspective, Is MADR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Mangalam Drugs Organics Stock Split?
Mangalam Drugs Organics has split 0 times.
How Many Employees Does Mangalam Drugs Organics Have?
Mangalam Drugs Organics has 432 employees.
What is the current trading status of Mangalam Drugs Organics (MADR)?
As of 17 Aug 2025, Mangalam Drugs Organics (MADR) is trading at a price of 82.75, with a previous close of 74.36. The stock has fluctuated within a day range of 74.50 to 86.90, while its 52-week range spans from 70.10 to 144.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.